Cargando…
P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184784/ http://dx.doi.org/10.1016/S1569-1993(22)00412-X |
| _version_ | 1784724603899215872 |
|---|---|
| author | Vincken, S. Knoop, C. Verbanck, S. Buyck, N. Vanderhelst, E. |
| author_facet | Vincken, S. Knoop, C. Verbanck, S. Buyck, N. Vanderhelst, E. |
| author_sort | Vincken, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9184784 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91847842022-06-10 P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation Vincken, S. Knoop, C. Verbanck, S. Buyck, N. Vanderhelst, E. J Cyst Fibros Poster Sessions European Cystic Fibrosis Society. 2022-06 2022-06-10 /pmc/articles/PMC9184784/ http://dx.doi.org/10.1016/S1569-1993(22)00412-X Text en Copyright © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Sessions Vincken, S. Knoop, C. Verbanck, S. Buyck, N. Vanderhelst, E. P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation |
| title | P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation |
| title_full | P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation |
| title_fullStr | P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation |
| title_full_unstemmed | P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation |
| title_short | P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation |
| title_sort | p079 real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for f508del and heterozygous for f508del and a residual function mutation |
| topic | Poster Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184784/ http://dx.doi.org/10.1016/S1569-1993(22)00412-X |
| work_keys_str_mv | AT vinckens p079reallifedataontheefficacyandsafetyoftezacaftorivacaftorinpeoplelivingwithcysticfibrosishomozygousforf508delandheterozygousforf508delandaresidualfunctionmutation AT knoopc p079reallifedataontheefficacyandsafetyoftezacaftorivacaftorinpeoplelivingwithcysticfibrosishomozygousforf508delandheterozygousforf508delandaresidualfunctionmutation AT verbancks p079reallifedataontheefficacyandsafetyoftezacaftorivacaftorinpeoplelivingwithcysticfibrosishomozygousforf508delandheterozygousforf508delandaresidualfunctionmutation AT buyckn p079reallifedataontheefficacyandsafetyoftezacaftorivacaftorinpeoplelivingwithcysticfibrosishomozygousforf508delandheterozygousforf508delandaresidualfunctionmutation AT vanderhelste p079reallifedataontheefficacyandsafetyoftezacaftorivacaftorinpeoplelivingwithcysticfibrosishomozygousforf508delandheterozygousforf508delandaresidualfunctionmutation |